T13

2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)benzenesulfonamide

Created:	2009-05-28
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where T13 is found as a standalone ligand1 entries where T13 is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	0
Bond Count	32
Aromatic Bond Count	12

2D diagram of T13

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxyphenyl)benzenesulfonamide
Systematic Name (OpenEye OEToolkits)	2,3,4,5,6-pentafluoro-N-(3-fluoro-4-methoxy-phenyl)benzenesulfonamide
Formula	C₁₃ H₇ F₆ N O₃ S
Molecular Weight	371.255
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Fc1cc(ccc1OC)NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F
SMILES	CACTVS	3.341	COc1ccc(N[S](=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F
SMILES	OpenEye OEToolkits	1.5.0	COc1ccc(cc1F)NS(=O)(=O)c2c(c(c(c(c2F)F)F)F)F
Canonical SMILES	CACTVS	3.341	COc1ccc(N[S](=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1F
Canonical SMILES	OpenEye OEToolkits	1.5.0	COc1ccc(cc1F)NS(=O)(=O)c2c(c(c(c(c2F)F)F)F)F
InChI	InChI	1.03	InChI=1S/C13H7F6NO3S/c1-23-7-3-2-5(4-6(7)14)20-24(21,22)13-11(18)9(16)8(15)10(17)12(13)19/h2-4,20H,1H3
InChIKey	InChI	1.03	ROZCIVXTLACYNY-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB16103
Name	Batabulin
Groups	investigational
Description	Batabulin is under investigation in clinical trial NCT00057382 (T138067 Versus Doxorubicin in Chemotherapy-naive, Unresectable, Hepatocellular Carcinoma Patients).
Synonyms	Batabulin
Categories	Amides Benzene Derivatives Hydrocarbons, Fluorinated Hydrocarbons, Halogenated Sulfonamides Sulfones Sulfur Compounds
CAS number	195533-53-0

Related Resource References

Resource Name	Reference
PubChem	216324
ChEMBL	CHEMBL79280

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.